Forecast & Rating4 analysts currently cover NeuroSense Therapeutics - Unit, of which 4 give a positive rating. The average price target is $137.50, about 1946.1% upside from the current price of $6.72. Coverage is limited, so the data is for reference only. Data as of Sep 13, 2026; this does not constitute investment advice.
Sep 3, 2026Price forecast
$137.501946.13%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met3.7%
Stock price$6.72
Avg. target$137.5
High target$180
Low target$60
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.